Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael O Montgomery

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of the American Academy of Dermatology|August 28, 2012
Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United StatesIrene Cosmatos, Amy Matcho, Rachel Weinstein, et al.
Journal of the American Academy of Dermatology|October 16, 2013
Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United StatesIrene Cosmatos, Amy Matcho, Rachel Weinstein, et al.
Journal of the American Academy of Dermatology|February 2, 2010
Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trialAnnika Grant, Tayler Gonzalez, Michael O Montgomery, et al.
Journal of Vascular and Interventional Radiology : JVIR|February 14, 2004
Clot lysis in a primate model of peripheral arterial occlusive disease with use of systemic or intraarterial reteplase: addition of abciximab results in improved vessel reperfusionMarian T Nakada, Michael O Montgomery, Mark A Nedelman, et al.
Journal of Cellular Biochemistry|July 20, 2004
Expression and function of periostin-isoforms in boneJudith Litvin, Abdul-Hafez Selim, Michael O Montgomery, et al.
Neurosurgery|August 18, 2006
Intra-arterial reteplase and intravenous abciximab in patients with acute ischemic stroke: an open-label, dose-ranging, phase I studyAdnan I Qureshi, Pansy Harris-Lane, Jawad F Kirmani, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of the American Academy of Dermatology|August 28, 2012
Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United StatesIrene Cosmatos, Amy Matcho, Rachel Weinstein, et al.
Journal of the American Academy of Dermatology|October 16, 2013
Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United StatesIrene Cosmatos, Amy Matcho, Rachel Weinstein, et al.
Journal of the American Academy of Dermatology|February 2, 2010
Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trialAnnika Grant, Tayler Gonzalez, Michael O Montgomery, et al.
Journal of Vascular and Interventional Radiology : JVIR|February 14, 2004
Clot lysis in a primate model of peripheral arterial occlusive disease with use of systemic or intraarterial reteplase: addition of abciximab results in improved vessel reperfusionMarian T Nakada, Michael O Montgomery, Mark A Nedelman, et al.
Journal of Cellular Biochemistry|July 20, 2004
Expression and function of periostin-isoforms in boneJudith Litvin, Abdul-Hafez Selim, Michael O Montgomery, et al.
Neurosurgery|August 18, 2006
Intra-arterial reteplase and intravenous abciximab in patients with acute ischemic stroke: an open-label, dose-ranging, phase I studyAdnan I Qureshi, Pansy Harris-Lane, Jawad F Kirmani, et al.
Pageof 1